HEADER LIPID TRANSPORT, HYDROLASE 12-OCT-20 7KEV TITLE PCSK9 IN COMPLEX WITH A CYCLIC PEPTIDE LDLR DISRUPTOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 PROPEPTIDE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEURAL APOPTOSIS-REGULATED CONVERTASE 1,NARC-1,PROPROTEIN COMPND 5 CONVERTASE 9,PC9,SUBTILISIN/KEXIN-LIKE PROTEASE PC9; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: NEURAL APOPTOSIS-REGULATED CONVERTASE 1,NARC-1,PROPROTEIN COMPND 11 CONVERTASE 9,PC9,SUBTILISIN/KEXIN-LIKE PROTEASE PC9; COMPND 12 EC: 3.4.21.-; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: CYCLIC PEPTIDE LDLR DISRUPTOR; COMPND 16 CHAIN: C; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PCSK9, NARC1, PSEC0052; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: PCSK9, NARC1, PSEC0052; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 20 ORGANISM_TAXID: 32630 KEYWDS PRO-PROTEIN CONVERTASE, CORONARY HEART DISEASE, HYPERCHOLESTEROLEMIA, KEYWDS 2 LOW DENSITY LIPOPROTEIN RECEPTOR, AUTOCATALYTIC CLEAVAGE, KEYWDS 3 CHOLESTEROL METABOLISM, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, KEYWDS 4 LIPID METABOLISM, PHOSPHORYLATION, PROTEASE, SECRETED, SERINE KEYWDS 5 PROTEASE, STEROID METABOLISM, ZYMOGEN, LIPID TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR G.SPRAGGON,R.CHOPRA REVDAT 3 18-OCT-23 7KEV 1 REMARK REVDAT 2 02-MAR-22 7KEV 1 JRNL REVDAT 1 24-NOV-21 7KEV 0 JRNL AUTH M.E.BROUSSEAU,K.B.CLAIRMONT,G.SPRAGGON,A.N.FLYER, JRNL AUTH 2 A.A.GOLOSOV,P.GROSCHE,J.AMIN,J.ANDRE,D.BURDICK,S.CAPLAN, JRNL AUTH 3 G.CHEN,R.CHOPRA,L.AMES,D.DUBIEL,L.FAN,R.GATTLEN, JRNL AUTH 4 D.KELLY-SULLIVAN,A.W.KOCH,I.LEWIS,J.LI,E.LIU,D.LUBICKA, JRNL AUTH 5 A.MARZINZIK,K.NAKAJIMA,D.NETTLETON,J.OTTL,M.PAN,T.PATEL, JRNL AUTH 6 L.PERRY,S.PICKETT,J.POIRIER,P.C.REID,X.PELLE,M.SEEPERSAUD, JRNL AUTH 7 V.SUBRAMANIAN,V.VERA,M.XU,L.YANG,Q.YANG,J.YU,G.ZHU, JRNL AUTH 8 L.G.MONOVICH JRNL TITL IDENTIFICATION OF A PCSK9-LDLR DISRUPTOR PEPTIDE WITH IN JRNL TITL 2 VIVO FUNCTION. JRNL REF CELL CHEM BIOL V. 29 249 2022 JRNL REFN ESSN 2451-9456 JRNL PMID 34547225 JRNL DOI 10.1016/J.CHEMBIOL.2021.08.012 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.N.HAMPTON,M.W.KNUTH,J.LI,J.L.HARRIS,S.A.LESLEY,G.SPRAGGON REMARK 1 TITL THE SELF-INHIBITED STRUCTURE OF FULL-LENGTH PCSK9 AT 1.9 A REMARK 1 TITL 2 REVEALS STRUCTURAL HOMOLOGY WITH RESISTIN WITHIN THE REMARK 1 TITL 3 C-TERMINAL DOMAIN. REMARK 1 REF PROC NATL ACAD SCI U S A V. 104 14604 2007 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.0703402104 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 15722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 785 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.6400 - 5.0900 0.91 2533 136 0.1961 0.2314 REMARK 3 2 5.0900 - 4.0400 0.93 2479 137 0.1965 0.2567 REMARK 3 3 4.0400 - 3.5300 0.94 2501 116 0.2271 0.3021 REMARK 3 4 3.5300 - 3.2100 0.95 2478 139 0.2501 0.2843 REMARK 3 5 3.2100 - 2.9800 0.96 2495 138 0.2888 0.3859 REMARK 3 6 2.9800 - 2.8000 0.94 2451 119 0.3078 0.3472 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.409 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.190 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4446 REMARK 3 ANGLE : 1.014 6026 REMARK 3 CHIRALITY : 0.052 694 REMARK 3 PLANARITY : 0.006 784 REMARK 3 DIHEDRAL : 16.927 1593 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KEV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000252369. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JAN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 130 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15722 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 74.656 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.14300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 1.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2QTW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20.0% PEG-6000, 0.1M TRIS, PH 8.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.11250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.62850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.22050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.62850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.11250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.22050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 29 REMARK 465 ALA A 30 REMARK 465 GLN A 31 REMARK 465 GLU A 32 REMARK 465 ASP A 33 REMARK 465 GLU A 34 REMARK 465 ASP A 35 REMARK 465 GLY A 36 REMARK 465 ASP A 37 REMARK 465 TYR A 38 REMARK 465 GLU A 39 REMARK 465 GLU A 40 REMARK 465 LEU A 41 REMARK 465 VAL A 42 REMARK 465 LEU A 43 REMARK 465 ALA A 44 REMARK 465 LEU A 45 REMARK 465 ARG A 46 REMARK 465 SER A 47 REMARK 465 GLU A 48 REMARK 465 GLU A 49 REMARK 465 ASP A 50 REMARK 465 GLY A 51 REMARK 465 LEU A 52 REMARK 465 ALA A 53 REMARK 465 GLU A 54 REMARK 465 ALA A 55 REMARK 465 PRO A 56 REMARK 465 GLU A 57 REMARK 465 HIS A 58 REMARK 465 GLY A 59 REMARK 465 THR A 60 REMARK 465 ALA B 168 REMARK 465 ASP B 169 REMARK 465 GLU B 170 REMARK 465 TYR B 171 REMARK 465 GLN B 172 REMARK 465 PRO B 173 REMARK 465 PRO B 174 REMARK 465 ASP B 175 REMARK 465 GLY B 176 REMARK 465 GLY B 177 REMARK 465 GLY B 213 REMARK 465 THR B 214 REMARK 465 ARG B 215 REMARK 465 PHE B 216 REMARK 465 HIS B 217 REMARK 465 ARG B 218 REMARK 465 GLN B 219 REMARK 465 THR B 448 REMARK 465 HIS B 449 REMARK 465 GLY B 450 REMARK 465 ALA B 451 REMARK 465 GLY B 452 REMARK 465 TRP B 453 REMARK 465 PHE B 515 REMARK 465 GLY B 516 REMARK 465 ALA B 542 REMARK 465 GLU B 543 REMARK 465 ALA B 544 REMARK 465 SER B 545 REMARK 465 MET B 546 REMARK 465 GLY B 547 REMARK 465 LEU B 571 REMARK 465 GLY B 572 REMARK 465 THR B 573 REMARK 465 HIS B 574 REMARK 465 LYS B 575 REMARK 465 PRO B 576 REMARK 465 PRO B 577 REMARK 465 VAL B 578 REMARK 465 LEU B 579 REMARK 465 ARG B 580 REMARK 465 PRO B 581 REMARK 465 ARG B 582 REMARK 465 GLY B 583 REMARK 465 ARG B 592 REMARK 465 PRO B 616 REMARK 465 ALA B 617 REMARK 465 PRO B 618 REMARK 465 ASP B 660 REMARK 465 VAL B 661 REMARK 465 SER B 662 REMARK 465 THR B 663 REMARK 465 THR B 664 REMARK 465 GLY B 665 REMARK 465 SER B 666 REMARK 465 THR B 667 REMARK 465 SER B 668 REMARK 465 GLU B 669 REMARK 465 GLU B 670 REMARK 465 HIS B 683 REMARK 465 LEU B 684 REMARK 465 ALA B 685 REMARK 465 GLN B 686 REMARK 465 ALA B 687 REMARK 465 SER B 688 REMARK 465 GLN B 689 REMARK 465 GLU B 690 REMARK 465 LEU B 691 REMARK 465 GLN B 692 REMARK 465 HIS B 693 REMARK 465 HIS B 694 REMARK 465 HIS B 695 REMARK 465 HIS B 696 REMARK 465 HIS B 697 REMARK 465 HIS B 698 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O11 WCM C 7 N5 WCM C 8 1.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 612 CG GLU B 612 CD 0.093 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 167 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 167 NE - CZ - NH2 ANGL. DEV. = -5.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 84 -46.71 -24.76 REMARK 500 HIS A 113 139.68 179.15 REMARK 500 HIS A 116 138.45 -177.00 REMARK 500 HIS A 139 -7.85 73.30 REMARK 500 ASP B 186 -118.68 -160.06 REMARK 500 ASP B 192 52.29 -101.70 REMARK 500 ASN B 207 88.15 -150.21 REMARK 500 ALA B 242 73.51 -110.29 REMARK 500 GLN B 278 70.15 -150.79 REMARK 500 VAL B 280 -153.52 -143.11 REMARK 500 PRO B 288 43.82 -86.69 REMARK 500 TYR B 293 117.93 -38.52 REMARK 500 PRO B 430 152.14 -48.62 REMARK 500 HIS B 464 140.50 -35.97 REMARK 500 SER B 465 -72.90 -81.42 REMARK 500 ASP B 480 32.65 -94.37 REMARK 500 ASN B 586 43.82 -97.53 REMARK 500 HIS B 613 104.57 -169.71 REMARK 500 THR B 641 9.45 -65.78 REMARK 500 ASP B 651 -111.52 58.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 801 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 VAL B 333 O REMARK 620 2 ASP B 360 OD2 65.8 REMARK 620 N 1 DBREF 7KEV A 29 152 UNP Q8NBP7 PCSK9_HUMAN 29 152 DBREF 7KEV B 153 692 UNP Q8NBP7 PCSK9_HUMAN 153 692 DBREF 7KEV C 1 14 PDB 7KEV 7KEV 1 14 SEQADV 7KEV ILE B 474 UNP Q8NBP7 VAL 474 VARIANT SEQADV 7KEV GLU B 670 UNP Q8NBP7 GLY 670 VARIANT SEQADV 7KEV HIS B 693 UNP Q8NBP7 EXPRESSION TAG SEQADV 7KEV HIS B 694 UNP Q8NBP7 EXPRESSION TAG SEQADV 7KEV HIS B 695 UNP Q8NBP7 EXPRESSION TAG SEQADV 7KEV HIS B 696 UNP Q8NBP7 EXPRESSION TAG SEQADV 7KEV HIS B 697 UNP Q8NBP7 EXPRESSION TAG SEQADV 7KEV HIS B 698 UNP Q8NBP7 EXPRESSION TAG SEQRES 1 A 124 ARG ALA GLN GLU ASP GLU ASP GLY ASP TYR GLU GLU LEU SEQRES 2 A 124 VAL LEU ALA LEU ARG SER GLU GLU ASP GLY LEU ALA GLU SEQRES 3 A 124 ALA PRO GLU HIS GLY THR THR ALA THR PHE HIS ARG CYS SEQRES 4 A 124 ALA LYS ASP PRO TRP ARG LEU PRO GLY THR TYR VAL VAL SEQRES 5 A 124 VAL LEU LYS GLU GLU THR HIS LEU SER GLN SER GLU ARG SEQRES 6 A 124 THR ALA ARG ARG LEU GLN ALA GLN ALA ALA ARG ARG GLY SEQRES 7 A 124 TYR LEU THR LYS ILE LEU HIS VAL PHE HIS GLY LEU LEU SEQRES 8 A 124 PRO GLY PHE LEU VAL LYS MET SER GLY ASP LEU LEU GLU SEQRES 9 A 124 LEU ALA LEU LYS LEU PRO HIS VAL ASP TYR ILE GLU GLU SEQRES 10 A 124 ASP SER SER VAL PHE ALA GLN SEQRES 1 B 546 SER ILE PRO TRP ASN LEU GLU ARG ILE THR PRO PRO ARG SEQRES 2 B 546 TYR ARG ALA ASP GLU TYR GLN PRO PRO ASP GLY GLY SER SEQRES 3 B 546 LEU VAL GLU VAL TYR LEU LEU ASP THR SER ILE GLN SER SEQRES 4 B 546 ASP HIS ARG GLU ILE GLU GLY ARG VAL MET VAL THR ASP SEQRES 5 B 546 PHE GLU ASN VAL PRO GLU GLU ASP GLY THR ARG PHE HIS SEQRES 6 B 546 ARG GLN ALA SER LYS CYS ASP SER HIS GLY THR HIS LEU SEQRES 7 B 546 ALA GLY VAL VAL SER GLY ARG ASP ALA GLY VAL ALA LYS SEQRES 8 B 546 GLY ALA SER MET ARG SER LEU ARG VAL LEU ASN CYS GLN SEQRES 9 B 546 GLY LYS GLY THR VAL SER GLY THR LEU ILE GLY LEU GLU SEQRES 10 B 546 PHE ILE ARG LYS SER GLN LEU VAL GLN PRO VAL GLY PRO SEQRES 11 B 546 LEU VAL VAL LEU LEU PRO LEU ALA GLY GLY TYR SER ARG SEQRES 12 B 546 VAL LEU ASN ALA ALA CYS GLN ARG LEU ALA ARG ALA GLY SEQRES 13 B 546 VAL VAL LEU VAL THR ALA ALA GLY ASN PHE ARG ASP ASP SEQRES 14 B 546 ALA CYS LEU TYR SER PRO ALA SER ALA PRO GLU VAL ILE SEQRES 15 B 546 THR VAL GLY ALA THR ASN ALA GLN ASP GLN PRO VAL THR SEQRES 16 B 546 LEU GLY THR LEU GLY THR ASN PHE GLY ARG CYS VAL ASP SEQRES 17 B 546 LEU PHE ALA PRO GLY GLU ASP ILE ILE GLY ALA SER SER SEQRES 18 B 546 ASP CYS SER THR CYS PHE VAL SER GLN SER GLY THR SER SEQRES 19 B 546 GLN ALA ALA ALA HIS VAL ALA GLY ILE ALA ALA MET MET SEQRES 20 B 546 LEU SER ALA GLU PRO GLU LEU THR LEU ALA GLU LEU ARG SEQRES 21 B 546 GLN ARG LEU ILE HIS PHE SER ALA LYS ASP VAL ILE ASN SEQRES 22 B 546 GLU ALA TRP PHE PRO GLU ASP GLN ARG VAL LEU THR PRO SEQRES 23 B 546 ASN LEU VAL ALA ALA LEU PRO PRO SER THR HIS GLY ALA SEQRES 24 B 546 GLY TRP GLN LEU PHE CYS ARG THR VAL TRP SER ALA HIS SEQRES 25 B 546 SER GLY PRO THR ARG MET ALA THR ALA ILE ALA ARG CYS SEQRES 26 B 546 ALA PRO ASP GLU GLU LEU LEU SER CYS SER SER PHE SER SEQRES 27 B 546 ARG SER GLY LYS ARG ARG GLY GLU ARG MET GLU ALA GLN SEQRES 28 B 546 GLY GLY LYS LEU VAL CYS ARG ALA HIS ASN ALA PHE GLY SEQRES 29 B 546 GLY GLU GLY VAL TYR ALA ILE ALA ARG CYS CYS LEU LEU SEQRES 30 B 546 PRO GLN ALA ASN CYS SER VAL HIS THR ALA PRO PRO ALA SEQRES 31 B 546 GLU ALA SER MET GLY THR ARG VAL HIS CYS HIS GLN GLN SEQRES 32 B 546 GLY HIS VAL LEU THR GLY CYS SER SER HIS TRP GLU VAL SEQRES 33 B 546 GLU ASP LEU GLY THR HIS LYS PRO PRO VAL LEU ARG PRO SEQRES 34 B 546 ARG GLY GLN PRO ASN GLN CYS VAL GLY HIS ARG GLU ALA SEQRES 35 B 546 SER ILE HIS ALA SER CYS CYS HIS ALA PRO GLY LEU GLU SEQRES 36 B 546 CYS LYS VAL LYS GLU HIS GLY ILE PRO ALA PRO GLN GLU SEQRES 37 B 546 GLN VAL THR VAL ALA CYS GLU GLU GLY TRP THR LEU THR SEQRES 38 B 546 GLY CYS SER ALA LEU PRO GLY THR SER HIS VAL LEU GLY SEQRES 39 B 546 ALA TYR ALA VAL ASP ASN THR CYS VAL VAL ARG SER ARG SEQRES 40 B 546 ASP VAL SER THR THR GLY SER THR SER GLU GLU ALA VAL SEQRES 41 B 546 THR ALA VAL ALA ILE CYS CYS ARG SER ARG HIS LEU ALA SEQRES 42 B 546 GLN ALA SER GLN GLU LEU GLN HIS HIS HIS HIS HIS HIS SEQRES 1 C 14 ACE PHE VAL SER THR ALO WCM WCM ASP ARG PRO CYS GLY SEQRES 2 C 14 NH2 HET ACE C 1 3 HET ALO C 6 7 HET WCM C 7 23 HET WCM C 8 23 HET NH2 C 14 1 HET CA B 801 1 HETNAM ACE ACETYL GROUP HETNAM ALO ALLO-THREONINE HETNAM WCM (2S)-2-AMINO-3-(BIPHENYL-4-YL)-N-METHYL-N-[(2S)-1- HETNAM 2 WCM OXOPROPAN-2-YL]PROPANAMIDE (NON-PREFERRED NAME) HETNAM NH2 AMINO GROUP HETNAM CA CALCIUM ION FORMUL 3 ACE C2 H4 O FORMUL 3 ALO C4 H9 N O3 FORMUL 3 WCM 2(C19 H22 N2 O3) FORMUL 3 NH2 H2 N FORMUL 4 CA CA 2+ FORMUL 5 HOH *17(H2 O) HELIX 1 AA1 LYS A 69 PRO A 71 5 3 HELIX 2 AA2 HIS A 87 ARG A 105 1 19 HELIX 3 AA3 SER A 127 ASP A 129 5 3 HELIX 4 AA4 LEU A 130 LYS A 136 1 7 HELIX 5 AA5 PRO B 155 ILE B 161 1 7 HELIX 6 AA6 ASP B 224 GLY B 236 1 13 HELIX 7 AA7 VAL B 261 GLN B 278 1 18 HELIX 8 AA8 SER B 294 ARG B 306 1 13 HELIX 9 AA9 ASP B 321 CYS B 323 5 3 HELIX 10 AB1 GLY B 384 GLU B 403 1 20 HELIX 11 AB2 THR B 407 PHE B 418 1 12 HELIX 12 AB3 ASN B 425 PHE B 429 5 5 HELIX 13 AB4 PRO B 430 GLU B 431 5 2 HELIX 14 AB5 ASP B 432 THR B 437 1 6 SHEET 1 AA1 3 THR A 63 HIS A 65 0 SHEET 2 AA1 3 VAL A 140 ALA A 151 1 O ILE A 143 N THR A 63 SHEET 3 AA1 3 LYS B 258 THR B 260 -1 O GLY B 259 N VAL A 149 SHEET 1 AA2 6 LYS A 110 PHE A 115 0 SHEET 2 AA2 6 GLY A 121 LYS A 125 -1 O GLY A 121 N PHE A 115 SHEET 3 AA2 6 ARG A 73 LEU A 82 -1 N TYR A 78 O VAL A 124 SHEET 4 AA2 6 VAL A 140 ALA A 151 -1 O ASP A 146 N THR A 77 SHEET 5 AA2 6 LEU B 289 GLY B 292 -1 O ALA B 290 N PHE A 150 SHEET 6 AA2 6 TYR B 325 SER B 326 -1 O SER B 326 N GLY B 291 SHEET 1 AA3 7 VAL B 200 GLU B 206 0 SHEET 2 AA3 7 SER B 246 ARG B 251 1 O MET B 247 N MET B 201 SHEET 3 AA3 7 GLU B 181 ASP B 186 1 N LEU B 184 O LEU B 250 SHEET 4 AA3 7 LEU B 283 LEU B 287 1 O LEU B 286 N TYR B 183 SHEET 5 AA3 7 VAL B 310 ALA B 314 1 O VAL B 312 N LEU B 287 SHEET 6 AA3 7 ILE B 334 THR B 339 1 O ILE B 334 N THR B 313 SHEET 7 AA3 7 LEU B 361 PRO B 364 1 O ALA B 363 N GLY B 337 SHEET 1 AA4 2 THR B 347 LEU B 348 0 SHEET 2 AA4 2 LEU B 351 GLY B 352 -1 O LEU B 351 N LEU B 348 SHEET 1 AA5 2 ILE B 368 ALA B 371 0 SHEET 2 AA5 2 PHE B 379 GLN B 382 -1 O VAL B 380 N GLY B 370 SHEET 1 AA6 2 ALA B 420 LYS B 421 0 SHEET 2 AA6 2 LEU B 440 VAL B 441 -1 O VAL B 441 N ALA B 420 SHEET 1 AA7 3 PHE B 456 TRP B 461 0 SHEET 2 AA7 3 TYR B 521 LEU B 528 -1 O ALA B 524 N VAL B 460 SHEET 3 AA7 3 GLU B 482 PHE B 489 -1 N GLU B 482 O CYS B 527 SHEET 1 AA8 3 THR B 472 ALA B 475 0 SHEET 2 AA8 3 LYS B 506 ASN B 513 -1 O ALA B 511 N ALA B 473 SHEET 3 AA8 3 ARG B 495 GLN B 503 -1 N GLY B 497 O HIS B 512 SHEET 1 AA9 3 ASN B 533 ALA B 539 0 SHEET 2 AA9 3 SER B 595 HIS B 602 -1 O CYS B 600 N SER B 535 SHEET 3 AA9 3 HIS B 557 HIS B 565 -1 N VAL B 558 O CYS B 601 SHEET 1 AB1 3 GLU B 607 ILE B 615 0 SHEET 2 AB1 3 VAL B 672 ARG B 680 -1 O CYS B 678 N LYS B 609 SHEET 3 AB1 3 THR B 631 LEU B 638 -1 N LEU B 638 O THR B 673 SHEET 1 AB2 3 GLN B 621 ALA B 625 0 SHEET 2 AB2 3 THR B 653 ARG B 659 -1 O CYS B 654 N VAL B 624 SHEET 3 AB2 3 HIS B 643 VAL B 650 -1 N GLY B 646 O ARG B 657 SSBOND 1 CYS B 223 CYS B 255 1555 1555 2.04 SSBOND 2 CYS B 323 CYS B 358 1555 1555 2.06 SSBOND 3 CYS B 375 CYS B 378 1555 1555 2.44 SSBOND 4 CYS B 457 CYS B 527 1555 1555 2.02 SSBOND 5 CYS B 477 CYS B 526 1555 1555 2.02 SSBOND 6 CYS B 486 CYS B 509 1555 1555 2.04 SSBOND 7 CYS B 534 CYS B 601 1555 1555 2.03 SSBOND 8 CYS B 552 CYS B 600 1555 1555 1.63 SSBOND 9 CYS B 562 CYS B 588 1555 1555 2.00 SSBOND 10 CYS B 608 CYS B 679 1555 1555 2.03 SSBOND 11 CYS B 626 CYS B 678 1555 1555 2.03 SSBOND 12 CYS B 635 CYS B 654 1555 1555 2.04 LINK C ACE C 1 N PHE C 2 1555 1555 1.32 LINK CH3 ACE C 1 SG CYS C 12 1555 1555 1.76 LINK C THR C 5 N ALO C 6 1555 1555 1.34 LINK C ALO C 6 N5 WCM C 7 1555 1555 1.44 LINK C14 WCM C 7 N5 WCM C 8 1555 1555 1.44 LINK C14 WCM C 8 N ASP C 9 1555 1555 1.43 LINK C GLY C 13 N NH2 C 14 1555 1555 1.36 LINK O VAL B 333 CA CA B 801 1555 1555 3.05 LINK OD2 ASP B 360 CA CA B 801 1555 1555 2.80 CISPEP 1 SER B 326 PRO B 327 0 0.01 CRYST1 62.225 70.441 149.257 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016071 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014196 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006700 0.00000